Table 1.
Descriptive summary of the 11 studies done on prevalence and risk factors of human leishmaniasis in Ethiopia
Authors | Year of publication | Sample size | Type of test | Region of the study | Study setting | Prevalence (95% CI) |
---|---|---|---|---|---|---|
Ali et al. | 1993 | 730 | rK39 | SNNPR | Community | 36.4 (10.91–61.89) |
Negera et al. | 2008 | 1907 | rK39 | SNNPR | Community | 4.8 (− 13.54 to 23.14 |
Wondimeneh et al. | 2014 | 7161 | DAT | Amhara | Hospital | 39.1 (− 41.84 to 120.04) |
Bsrat et al. | 2015 | 2106 | rK39 | Tigray | Community | 14.0 (− 17.22 to 45.22) |
Abera et al. | 2016 | 289 | rK39 | Somali or Benshangul | Community | 6.9 (− 1.56 to 15.36) |
Bsrat et al. | 2018 | 329 | rK39 | Tigray | Community | 8.8 (− 1.28 to 18.88) |
Tedla et al. | 2018 | 26,511 | rK39 | Tigray | Hospital | 8.4 (− 80.21 to 97.01) |
Ayehu et al. | 2018 | 185 | rK39 | Amhara | Community | 7.6 (0.55–14.65) |
Bekele et al. | 2018 | 1682 | rK39 | SNNPR | Community | 8.6 (− 13.96 to 31.16) |
Alebie et al. | 2019 | 361 | rK39 | Somali or Benshangul | Community | 15.8 (2.22–29.38) |
Yohannes et al. | 2019 | 9622 | Clinical | Tigray | Community | 2.3 (− 26.50 to 31.10) |